SCHEMBL8893178

SCHEMBL8893178

Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1[N+](=O)[O-]

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 5/20 0.66
▸ LMNA P02545 2/20 0.57
▸ NT5E P21589 1/20 0.57
▸ HIF1A Q16665 1/20 0.57
▸ ADORA2A P29274 3/20 0.57
▸ ADORA2B P29275 2/20 0.56
▸ HPGD P15428 2/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ SLC29A1 Q99808 2/20 0.54
▸ DPP4 P27487 1/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ SLC28A1 O00337 1/20 0.54
▸ MAP3K7 O43318 1/20 0.54
▸ SLC28A2 O43868 1/20 0.54
▸ GAPDH P04406 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ ADORA1 P30542 1/20 0.54
▸ STAT6 P42226 1/20 0.54
▸ PI4KA P42356 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970946 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL899617 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL5033515 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL2014081 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL16555404 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL6663083 0.84 LMNA (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL14931005 0.83 CYP2C19 (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL343478 0.83 CYP2C19 (0.62) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL2424283 0.83 LMNA (0.64) ADORA3LMNANT5EHIF1AADORA2A
SCHEMBL11481461 0.83 LMNA (0.61) ADORA3LMNANT5EHIF1AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5683905-A Vectors and cell lines capable of correctly splicing exon regions GENENTECH, INC. (US) 1997-11-04 — — US disclosed
US-5668108-A Preparation of functional human factor VIII and pharmaceutical treatment therewith GENENTECH, INC. (US) 1997-09-16 — — US disclosed
US-5654147-A GENETIC ENGINEERING GENENTECH, INC. (US) 1997-08-05 — — US disclosed
US-5633150-A Preparation of functional human factor VIII GENENTECH, INC. (US) 1997-05-27 — — US disclosed
US-5618788-A ADMINISTERING RECOMBINANT FUNCTIONAL HUMAN FACTOR VIII TO TREAT BLOOD DISORDERS ASSOCIATED WITH DEFICIENCY GENENTECH, INC. (US) 1997-04-08 — — US disclosed
US-5618789-A RECOMBINANTLY PRODUCED; FREE OF VIRAL CONTAMINANTS; USED IN TREATMENT OF PATIENTS DIAGNOSED WITH FACTOR VIII COAGULANT DEFICIENCY GENENTECH, INC. (US) 1997-04-08 — — US disclosed
US-4965199-A Preparation of functional human factor VIII in mammalian cells using methotrexate based selection GENENTECH, INC. (US) 1990-10-23 — — US disclosed
EP-0385558-A2 Materials and methods for genome walking GENENTECH, INC. (US) 1990-09-05 — — EP disclosed
EP-0160457-A1 Human factor VIII, Compositions containing it, methods and materials for use in it production GENENTECH, INC. (US) 1985-11-06 — — EP disclosed
Send feedback